INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45m ago
HOUSE PTR5m ago
SEC 13F5m ago
ROBINHOOD CHAIN5m ago
Public company

FBRXForte Biosciences, Inc.

CIK 0001419041

EDGAR filingsOpen in network
Disclosed transactions20
Buys / sells0 / 0
Max Insider Score9
Connections5with evidence

FBRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KS
Kapoor Shivpreet SinghDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
18.4K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Brun Scott C.Director · Aug 27, 2026
  • ← Insider ofevidence
    Kornfeld StevenDirector · Aug 27, 2026
  • ← Insider ofevidence
    Kapoor Shivpreet SinghDirector · Jun 2, 2026
9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D
—
18.4K sh
Aug 27, 2026
Aug 27, 2026
traded Aug 27, 2026
+0d
SEC FORM 4

Evidence

9
KS
Kapoor Shivpreet SinghDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
2,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kapoor Shivpreet SinghDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
31.0K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
2,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
2,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
31.0K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Tender of shares
U—
3,960 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,200 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
800 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
2,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
31.0K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
18.4K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kapoor Shivpreet SinghDirector
FBRXForte Biosciences, Inc.
Grant or award
A—
18.4K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC FORM 4

Evidence

9
WA
Wagner Paul A.Director, SEE REMARKS
FBRXForte Biosciences, Inc.
Grant or award
A—
180.0K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

9
WA
Wagner Paul A.Director, SEE REMARKS
FBRXForte Biosciences, Inc.
Grant or award
A—
270.0K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

← Insider ofevidence
Wagner Paul A.
Director, SEE REMARKS · Jan 13, 2026